Investing.com -- Novo Nordisk (NYSE:NVO) is introducing NovoCare Pharmacy, a direct-to-patient delivery option offering Wegovy at a reduced price of $499 per month for certain cash-paying patients.The program is available to uninsured individuals and those with commercial insurance that does not cover obesity medicines, expanding access to the company’s blockbuster weight-loss drug.The announcem ...
PANAMA CITY (Reuters) - Panamanian President Jose Raul Mulino said on Wednesday morning that U.S. President Donald Trump was lying when he said that the North American leader’s administration was "reclaiming" the Panama Canal.Trump’s comments to Congress came after a deal led by U.S. firm BlackRock (NYSE:BLK) was announced earlier Tuesday to buy most of the $22.8 billion ports business of Hong ...
Investing.com -- Shares of Hims and Hers (NYSE:HIMS) fell 3% amidst news of Novo Nordisk (NYSE:NVO) introducing NovoCare Pharmacy, which directly impacts the competitive landscape by offering FDA-approved Wegovy (semaglutide) at a reduced monthly cost and with the convenience of home delivery for cash-paying patients.The decline follows Novo Nordisk’s press release on March 5, 2025, announcing t ...
By Ludwig BurgerFRANKFURT (Reuters) - Bayer (OTC:BAYRY) on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a four-month high as its CEO somewhat allayed investor impatience with his turnaround efforts. The German maker of drugs and farming pesticides said 2025 would be the most difficult in terms of financial performance, with ...